The NHP product licence application process in Canada trips up more first-time brand owners than any other step between formulation and shelf. Get the submission right and you receive an NPN in weeks. Get it wrong and Health Canada's clock resets while a competitor reaches market first. This guide walks through the process in the order you will actually face it, so your first filing is also your last revision.
Key Takeaways
- Every natural health product sold in Canada needs a Product Licence (NPN) before it goes to market.
- Application class (I, II, or III) determines review timelines, evidence depth, and how fast you get an NPN.
- A pre-cleared monograph is the fastest route for most single-herb and common-formula products.
- Site licensing and finished-product manufacturing run in parallel with the product licence, not after it.
- Most rejections trace back to evidence-claim mismatches and incomplete specifications, both avoidable.
Step 1: Confirm Your Product Needs the NHP Product Licence Application Process
Before anything else, confirm your product is regulated as a natural health product. The process covers herbal tinctures, vitamins, minerals, probiotics, and traditional medicines that make a health claim. Does your product carry a health claim and use a listed medicinal ingredient? Then it almost certainly needs a Product Licence number, known as an NPN.
Here's what that means in practice: you cannot legally sell or advertise the product in Canada until Health Canada issues that NPN. The licence attaches to a specific formulation, dose, and claim, so each distinct product needs its own application.
This is the point where many brand owners discover the regulatory path is longer than they planned for. So build a realistic timeline now, rather than after a rejection. It is the single best move a first-time applicant can make.
Step 2: Determine Your Application Class
The NHP product licence application process in Canada sorts every submission into one of three classes. The class you fall into drives your entire timeline. Class I covers products that match a single pre-cleared Health Canada monograph exactly. A Class II product draws on a combination of monographs or a labelling standard. Everything else falls into Class III, including products that rely on original published evidence.
The practical implication: Class I and II submissions move through review far faster, because Health Canada has already pre-assessed the evidence. A Class III submission asks the regulator to evaluate your supporting studies from scratch, which adds months.
For a first product, align your formulation and claim to an existing monograph wherever possible. That is the most reliable way to shorten the review. Specifically, it removes the largest single source of delay: original evidence assessment.
Step 3: Assemble Your NHP Application Package
You build a complete Product Licence Application in the official form and submit it through Health Canada's electronic system. The core of the package is your medicinal and non-medicinal ingredient list. Each ingredient needs its source material, potency, and dose form. Every medicinal ingredient must tie back to an accepted entry in the Natural Health Products Ingredients Database.
Alongside the formulation, you submit your recommended use, dose, duration of use, risk information, and any cautions. The claim you make must match the evidence tier your class allows. This is where most first-time applications run into trouble: the label claim is stronger than the cited evidence supports.
Finished-product specifications round out the package, covering identity, purity, and potency limits. Working with a GMP-compliant contract manufacturer early helps here. Your manufacturing partner supplies the specification detail Health Canada expects to see.
Step 4: Submit Your NHP Application and Respond to Health Canada
Once you submit, your application enters Health Canada's review queue. Health Canada assigns it a submission number you use to track status. A complete Class I or II application often clears within roughly 60 days. Class III reviews routinely run longer. However, those timelines assume a clean submission with no requests for more information.
If a reviewer issues an Information Request Notice, you have a fixed window to respond before Health Canada refuses the application. Respond fully and on time, because a refusal means starting over. As a result, building buffer into your launch calendar is wise.
Worth understanding before you proceed: the product licence is only one half of the regulatory picture. You must also make, package, and label the product at a licensed site. That brings us to the parallel track.
Step 5: Line Up Site Licensing and Manufacturing in Parallel
A common and costly assumption is that the application must finish before manufacturing begins. In reality, the two should run together. A holder of a valid Site Licence must make your finished product. The manufacturing, packaging, and labelling specifications then feed directly into your product licence submission.
Here's how a typical engagement handles it. First, the brand owner finalizes the formulation with a manufacturer. The manufacturer then provides the specification and stability data the application needs. Meanwhile, the product licence filing proceeds and production capacity is reserved. By the time the NPN arrives, the first batch is ready to run.
That parallel approach separates brands that launch on schedule from those that wait months after approval to even start production. Are you mapping your route to market? It helps to talk to a manufacturing partner about how the manufacturing and regulatory timelines fit together.
Published: June 26, 2026